Key result
Polish guidelines highlight family physicians' key role in managing dyslipidaemia to lower cardiovascular disease.
Dyslipidaemias are the most common yet the least well-controlled risk factor for cardiovascular disease (CVD) in Poland [1]. The main modifiable risk factors for atherosclerosis and its complications including ischaemic heart disease (IHD), stroke and peripheral artery disease (PAD) are: smoking, type 2 diabetes, arterial hypertension, inappropriate diet and eating habits, inadequate physical activity as well as the resulting overweight and obesity [6]. As shown by epidemiological studies conducted in Poland, there is a nationwide growth in the above risk factors (with the exception of smoking in the majority of age groups), which is attributable to the increasing prevalence of poor eating habits and sedentary lifestyle [1]. The elimination of risk factors represents one of the greatest challenges to be faced in the domain of public health. In order to rise to up to the challenge, wide-ranging population prevention measures are needed. However, family physicians as well as other health professionals (cardiologists, internists) have a special responsibility towards high-risk patients. The group definitely comprises a considerable proportion of dyslipidaemia patients. Consequently, dyslipidaemia management should be an element of a broader strategy targeted at lowering total CV risk and, hence, reducing mortality, morbidity and disability associated with CVD.
No takes yet. Share an insight, caveat, or question.
Banach et al. (2017) conducted a review in Dyslipidaemias. Dyslipidaemia management guidelines was evaluated. The 2016 PoLA/CFPiP/PCS guidelines highlight the critical role of family physicians in managing dyslipidaemias and associated modifiable risk factors to reduce cardiovascular disease in Poland.
Synapse has enriched 5 related papers. Consider them for comparative context: